Podcast Series: Improving Diagnosis and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Listen to the Podcasts and Earn CME Credit.
You may listen to these podcasts without registering for the site. If you are not claiming credit, please complete the short evaluation after you finish listening by clicking the "No Credit - Evaluation" button below.
If you want CME Credit for any of the podcasts, please register and log in by clicking the "Log In for CME Credit" button under each podcast below.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the New Jersey of Academy of Family Physicians. The New Jersey Academy of Family Physicians is accredited by the ACCME to provide continuing medical education for physicians.
The New Jersey Academy of Family Physicians designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PODCAST 1
Inside MASLD: The New Era of Liver Health
In this episode we will explore Metabolic dysfunction-associated steatotic liver disease (MASLD) - a newly named but increasingly common condition that affects nearly one in four adults globally. Formerly known as NAFLD, MASLD reflects a modern understanding of the strong link between liver health and metabolic risk factors like obesity, type 2 diabetes, and dyslipidemia.
Join hosts Dr. Elizabeth Zheng and Dr. Nghiem Ha as we break down the origins of the new terminology, walk through key diagnostic criteria, and discuss the practical steps clinicians can take for early identification and management. We also explore non-invasive screening tools, lifestyle-based interventions, and emerging treatment options that promise to reshape liver care in the coming years.
Whether you're a seasoned specialist or a frontline provider, this episode offers a clear and accessible overview of how MASLD fits into the evolving landscape of metabolic health.
PODCAST 2
MASLD in Primary Care: What Every Clinician Needs to Know
In this focused episode, we zoom in on the crucial role of primary care providers in identifying and managing MASLD (Metabolic dysfunction-associated steatotic liver disease)—a silent, yet increasingly prevalent condition now recognized as the most common chronic liver disease worldwide.
Hosts Dr. Elizabeth Zheng and Dr. Nghiem Ha walk you through a practical and action-oriented guide to spotting early signs of MASLD, using simple non-invasive screening tools like FIB-4, and initiating impactful first-line interventions in the primary care setting. We’ll also discuss how to counsel patients effectively, when to escalate care, and how MASLD fits into broader cardiometabolic risk management.
If you're a busy clinician seeking clear, concise strategies to tackle MASLD in everyday practice, this episode is your go-to resource.
PODCAST 3
Co-Managing MASLD: A Team-Based Approach
Managing MASLD (Metabolic dysfunction-associated steatotic liver disease) effectively requires more than just a single clinician—it demands coordinated, interdisciplinary care. In this episode, hosts Dr. Elizabeth Zheng and Dr. Nghiem Ha explore how specialists and primary care providers can work together to streamline MASLD diagnosis, risk stratification, and management.
We break down the roles of key care team members—PCPs, endocrinologists, hepatologists, and cardiologists—and explore how shared responsibility and communication can prevent care gaps. Through a real-world case study and discussion of practical tools like shared EHRs, care pathways, and referral triggers, this episode offers actionable strategies to integrate MASLD care into routine clinical workflows.
If you're looking to improve care coordination and build more effective referral relationships, this episode will equip you with the insight and tools needed to tackle MASLD as a team.
PODCAST 4
Behind the Guidelines: The Future of MASLD Care
The landscape of liver disease is changing—and so are the clinical frameworks that guide its diagnosis and treatment. In this forward-looking episode, Dr. Elizabeth Zheng and Dr. Nghiem Ha take you beyond the basics of MASLD (Metabolic dysfunction-associated steatotic liver disease) to explore emerging guidelines, innovations in diagnostics, and the evolving role of interdisciplinary care.
We unpack recent updates from major hepatology societies, discuss next-generation non-invasive tools, and explore cutting-edge therapies currently in the pipeline. With MASLD now positioned at the intersection of hepatology, endocrinology, and cardiometabolic care, clinicians must stay ahead of evolving science and clinical models.